Bio Age Labs, Inc. BIOA
We take great care to ensure that the data presented and summarized in this overview for BioAge Labs, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in BIOA
Top Purchases
Top Sells
About BIOA
Insider Transactions at BIOA
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 27
2024
|
Patrick G Enright |
BUY
Open market or private purchase
|
Indirect |
400,000
+18.95%
|
$7,200,000
$18.0 P/Share
|
|
Sep 27
2024
|
Patrick G Enright |
BUY
Conversion of derivative security
|
Indirect |
1,310,589
+50.0%
|
-
|
|
Sep 27
2024
|
Vijay Satyanand Pande |
BUY
Open market or private purchase
|
Indirect |
900,000
+50.0%
|
$16,200,000
$18.0 P/Share
|
|
Sep 27
2024
|
Vijay Satyanand Pande |
BUY
Conversion of derivative security
|
Indirect |
2,113,975
+43.64%
|
-
|
|
Sep 27
2024
|
James Healy |
BUY
Open market or private purchase
|
Indirect |
666,665
+44.18%
|
$11,999,970
$18.0 P/Share
|
|
Sep 27
2024
|
James Healy |
BUY
Conversion of derivative security
|
Indirect |
1,638,236
+50.0%
|
-
|
Last 12 Months Summary
Buy / Acquisition
7.03M
Shares
From
6
Insiders
| Conversion of derivative security | 5.06M shares |
|---|---|
| Open market or private purchase | 1.97M shares |
Sell / Disposition
0
Shares
From
0
Insiders